Hypercalcemia of Malignancy for Internist
Article Sidebar
Main Article Content
Abstract
In general practice, internists face oncologic malignancy more than before because cancer patients have long survival time due to effective anticancer treatment. Hypercalcemia of malignancy is one of the oncologic emergencies, and it causes death if misdiagnosis and malpractice to resolve the problems. On the other hand, if the internist is the proper initial management, it is better outcomes.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 1990;112(7):499-504. doi: 10.7326/0003-4819-112-7-499.
Guise TA, Wysolmerski JJ. Cancer-Associated Hypercalcemia. N Engl J Med 2022;386(15):1443-51. doi: 10.1056/NEJMcp2113128.
Stewart AF. Clinical practice. Hypercalcemia associated with cancer.N Engl J Med 2005;352(4):373-9. doi: 10.1056/NEJMcp042806.
Hosking DJ, Cowley A, Bucknall CA. Rehydration in the treatment of severe hypercalcaemia. Q J Med 1981;50(200):473-81.
Wisneski LA. Salmon calcitonin in the acute management of hypercalcemia. Calcif Tissue Int 1990;46(Suppl):S26-30. doi: 10.1007/BF02553290.
Ling PJ, A'Hern RP, Hardy JR. Analysis of survival following treatment of tumour-induced hypercalcaemia with intravenous pamidronate (APD). Br J Cancer 1995;72(1):206-9. doi: 10.1038/bjc.1995.304.
Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol 2001;19(2):558-67. doi: 10.1200/JCO.2001.19.2.558.
Hu MI, Glezerman I, Leboulleux S, Insogna K, Gucalp R, Misiorowski W, et al. Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment. J Natl Cancer Inst 2013;105(18):1417-20. doi: 10.1093/jnci/djt225.
